BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18752052)

  • 21. Modulation of DNA fragmentation factor 40 nuclease activity by poly(ADP-ribose) polymerase-1.
    West JD; Ji C; Marnett LJ
    J Biol Chem; 2005 Apr; 280(15):15141-7. PubMed ID: 15703174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poly(ADP-ribose): PARadigms and PARadoxes.
    Bürkle A; Virág L
    Mol Aspects Med; 2013 Dec; 34(6):1046-65. PubMed ID: 23290998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The emerging role of poly(ADP-ribose) polymerase-1 in longevity.
    Bürkle A; Brabeck C; Diefenbach J; Beneke S
    Int J Biochem Cell Biol; 2005 May; 37(5):1043-53. PubMed ID: 15743677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantification of PARP Activity in Human Tissues: Ex Vivo Assays in Blood Cells and Immunohistochemistry in Human Biopsies.
    Horvath EM; Zsengellér ZK; Szabo C
    Methods Mol Biol; 2017; 1608():19-26. PubMed ID: 28695500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of telomerase activity by reduction of poly(ADP-ribosyl)ation of TERT and TEP1/TP1 expression in HeLa cells with knocked down poly(ADP-ribose) polymerase-1 (PARP-1) gene.
    Ghosh U; Das N; Bhattacharyya NP
    Mutat Res; 2007 Feb; 615(1-2):66-74. PubMed ID: 17141279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New polymorphisms in the human poly(ADP-ribose) polymerase-1 coding sequence: lack of association with longevity or with increased cellular poly(ADP-ribosyl)ation capacity.
    Cottet F; Blanché H; Verasdonck P; Le Gall I; Schächter F; Bürkle A; Muiras ML
    J Mol Med (Berl); 2000; 78(8):431-40. PubMed ID: 11097112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased poly(ADP-ribosyl)ation of nuclear proteins in Alzheimer's disease.
    Love S; Barber R; Wilcock GK
    Brain; 1999 Feb; 122 ( Pt 2)():247-53. PubMed ID: 10071053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions.
    D'Amours D; Desnoyers S; D'Silva I; Poirier GG
    Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):249-68. PubMed ID: 10455009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity.
    Tentori L; Muzi A; Dorio AS; Bultrini S; Mazzon E; Lacal PM; Shah GM; Zhang J; Navarra P; Nocentini G; Cuzzocrea S; Graziani G
    Eur J Cancer; 2008 Jun; 44(9):1302-14. PubMed ID: 18440222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of zinc on cellular poly(ADP-ribosyl)ation capacity.
    Kunzmann A; Dedoussis G; Jajte J; Malavolta M; Mocchegiani E; Bürkle A
    Exp Gerontol; 2008 May; 43(5):409-14. PubMed ID: 18022337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poly(ADP-ribosyl)ation polymerases: mechanism and new target of anticancer therapy.
    Heitz F; Harter P; Ewald-Riegler N; Papsdorf M; Kommoss S; du Bois A
    Expert Rev Anticancer Ther; 2010 Jul; 10(7):1125-36. PubMed ID: 20645701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of simulated microgravity conditions on poly(ADP-ribose) polymerase activity in primary cultures of adult rat hepatocytes.
    Cesarone CF; Pippia P; Demori I; Scarabelli L; Fugassa E
    J Gravit Physiol; 2001 Jul; 8(1):P127-8. PubMed ID: 12650200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poly(ADP-ribosyl)ation of p53 in vitro and in vivo modulates binding to its DNA consensus sequence.
    Simbulan-Rosenthal CM; Rosenthal DS; Luo RB; Samara R; Jung M; Dritschilo A; Spoonde A; Smulson ME
    Neoplasia; 2001; 3(3):179-88. PubMed ID: 11494111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of poly(ADP-ribose) polymerase-1 by arsenite interferes with repair of oxidative DNA damage.
    Ding W; Liu W; Cooper KL; Qin XJ; de Souza Bergo PL; Hudson LG; Liu KJ
    J Biol Chem; 2009 Mar; 284(11):6809-17. PubMed ID: 19056730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poly(ADP-ribosylation) and genomic stability.
    Oei SL; Keil C; Ziegler M
    Biochem Cell Biol; 2005 Jun; 83(3):263-9. PubMed ID: 15959554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-Like Growth Factor II mRNA-Binding Protein 3 Expression Correlates with Poor Prognosis in Acral Lentiginous Melanoma.
    Sheen YS; Liao YH; Lin MH; Chiu HC; Jee SH; Liau JY; Chang YL; Chu CY
    PLoS One; 2016; 11(1):e0147431. PubMed ID: 26796627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generating Protein-Linked and Protein-Free Mono-, Oligo-, and Poly(ADP-Ribose) In Vitro.
    Lin KY; Huang D; Kraus WL
    Methods Mol Biol; 2018; 1813():91-108. PubMed ID: 30097863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cleavage of automodified poly(ADP-ribose) polymerase during apoptosis. Evidence for involvement of caspase-7.
    Germain M; Affar EB; D'Amours D; Dixit VM; Salvesen GS; Poirier GG
    J Biol Chem; 1999 Oct; 274(40):28379-84. PubMed ID: 10497198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PARP-1 interaction with VP1 capsid protein regulates polyomavirus early gene expression.
    Carbone M; Reale A; Di Sauro A; Sthandier O; Garcia MI; Maione R; Caiafa P; Amati P
    J Mol Biol; 2006 Nov; 363(4):773-85. PubMed ID: 16979186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The expression of poly(ADP-ribose) polymerase during differentiation-linked DNA replication reveals that it is a component of the multiprotein DNA replication complex.
    Simbulan-Rosenthal CM; Rosenthal DS; Hilz H; Hickey R; Malkas L; Applegren N; Wu Y; Bers G; Smulson ME
    Biochemistry; 1996 Sep; 35(36):11622-33. PubMed ID: 8794742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.